Concepedia

Eva Sum

ES

5

Publications

495

Citations

5

H-Index

2008

Active since

Affiliations

Roche (Switzerland)(Current)

University of Lausanne

Eva Sum is an author at Roche (Switzerland) specializing in medicine, tumor immunology, and t cell immunity.

ORCID

Top concepts

Publications per year

2008–2022

5

Publications

5

Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy

Maud Mayoux, Andreas Roller, Vesna Pulko et al. · Science Translational Medicine · 2020 · 361 citations

, , +11

Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity

Eva Sum, Moritz Rapp, Philipp Fröbel et al. · Clinical Cancer Research · 2021 · 57 citations · Full text

CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors

Sara Labiano, Vincent Roh, Céline Godfroid et al. · Clinical Cancer Research · 2021 · 37 citations · Full text

The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation

Eva Sum, Moritz Rapp, Harald Dürr et al. · Journal for ImmunoTherapy of Cancer · 2022 · 24 citations · Full text

Tonic and Phasic Pyloric Activity in Response to CCK-Octapeptide

Frank K. Friedenberg, Joshua DeSipio, Annapurna Korimilli et al. · Digestive Diseases and Sciences · 2008 · 16 citations

, , +4

Rows per page

1–5 of 5